Thursday, December 18, 2014 | Latest E-book
You are here:
Piramal Healthcare
#

Piramal Healthcare

Get Alerts

Articles

View all

Cabinet may decide to reduce FDI in pharma to 49 percent

Nov 24, 2013

Cabinet may decide to reduce FDI in pharma to 49 percent

"MNCs which are acquiring domestic firms have spent less than one percent of their total sales in R&D in India. They are doing only clinical trials in India and not actual drug development work," #India #Piramal Healthcare #NewsTracker #FDI #Ranbaxy #Pharma #Daiichi Sankyo #Multinational Companies #Abbot Laboratories
Will Piramal sell its 11% stake in Vodafone this year?

Apr 05, 2013

Will Piramal sell its 11% stake in Vodafone this year?

Piramal Healthcare had picked up 11 percent stake for Rs 5,900 crore in two tranches in the Indian arm of Vodafone #Vodafone #Piramal Healthcare #CorporateStrategy #stake sale
Why Piramal Healthcare wants to change its name

Jul 19, 2012

Why Piramal Healthcare wants to change its name

Pharma major Piramal Healthcare is set to be renamed as Piramal Enterprises following its entry into diversified business activities in the recent past. #Piramal Healthcare Limited #CorporateStrategy #Pharmaceutical industry #Name change
RIL  repurchases shares worth Rs 2,512 in  biggest  buyback

Jul 17, 2012

RIL repurchases shares worth Rs 2,512 in biggest buyback

Mukesh Ambani-led Reliance Industries has repurchased shares worth Rs 2,512 crore from its public shareholdersmaking it the country's biggest share buyback programme ever #Reliance Industries #Mukesh Ambani #Piramal Healthcare #CompanyWatch #share buyback

BLOG POSTS

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

May 09, 2011

Flop show? Indian pharma rolls back its drug discovery ambitions

Indian pharmaceutical companies have tried to speed up drug discoveries by hiving research off into separate companies. But as the Piramal decision shows, they are remerging these companies. Has the strategy failed? #Piramal Healthcare #Dr Reddy's #Sun Pharma #Drug research #NCEs #CorporateStrategy